High-dose Spinraza regimen approved for spinal muscular atrophy

What this means

Spinraza is an injected drug that helps treat spinal muscular atrophy by boosting a protein needed for muscle movement. The FDA just approved a higher-dose version of Spinraza for patients with this rare nerve-muscle disease. This could give doctors more flexibility in dosing for patients who may need stronger treatment to manage their symptoms.